Is BG a Buy or a Sell? The Bull and Bear Case (2026)

That depends on which case you find more convincing, and both are on this page. The bull case rests on Viterra merger scale and synergies, with revenue (ttm) at ~$92 billion. The bear case rests on bunge's earnings are highly cyclical and depend on commodity crush margins, harvest sizes, and trade flows it cannot control, so a compression in crush spreads can cut profits sharply. Analysts covering it are spread from $116.00 to $155.00, which is itself a signal that this is genuinely contested. If you believe the thesis, the real questions become sizing and overlap rather than timing. Walnut is not an investment adviser and this is not a recommendation.

Nobody can answer that for you, and the honest version of the question is narrower: has anything changed in the reason you bought it? The bear case on this page is the place to check. Bunge's earnings are highly cyclical and depend on commodity crush margins, harvest sizes, and trade flows it cannot control, so a compression in crush spreads can cut profits sharply. If that risk is what you were worried about and it is now playing out, that is a real signal. If the price simply fell while the thesis held, that is a different situation entirely. The most pessimistic published target is $116.00, +9.3% from the $106.14 price, which is one analyst's downside case rather than a floor. Walnut is not an investment adviser.

Viterra merger scale and synergies. The completed Viterra combination has lifted Bunge's trailing revenue to roughly $92 billion as of mid-2026, up from about $53 billion in 2024, and adds a leading grain-trading and origination network to Bunge's oilseed-processing strength. The most optimistic analyst target on BG is $155.00, +46.0% from the $106.14 price. That figure is only reachable if this thesis works close to its best case.

Bunge's earnings are highly cyclical and depend on commodity crush margins, harvest sizes, and trade flows it cannot control, so a compression in crush spreads can cut profits sharply. Expanded soybean and corn production in Brazil and Argentina intensifies competition and can pressure US export economics and margins, and US-China trade relations (including a tariff agreement reported in late September 2026) remain a swing factor for farm-commodity flows. Integrating Viterra is a large, multi-year undertaking with execution, cultural, and cost risk, and the balance sheet now carries about $17 billion of debt against under $1 billion of cash, with trailing free cash flow of roughly negative $6.5 billion as working capital swelled. Biofuel and renewable-diesel policy shifts, tariffs, currency swings, and weather all add volatility to results. Because much of the bull case rests on a forecast earnings recovery, a shortfall against those estimates could weigh on the stock, which had already slipped about 13% over the three months to October 16, 2026. The most pessimistic published target is $116.00, +9.3% from the current price, which is roughly what the stock is worth if these risks bite rather than the drivers.

Bunge Global SA is a leading global agribusiness and food company that sources, stores, processes, transports, and sells agricultural commodities and food ingredients.

Decide that in advance, because it is far harder to think clearly once a position is moving against you. The concrete tripwires here: the driver behind the bull case (Viterra merger scale and synergies) stalling in the reported numbers rather than in the narrative, the risk above (bunge's earnings are highly cyclical and depend on commodity crush margins, harvest sizes, and trade flows it cannot control, so a compression in crush spreads can cut profits sharply) turning from a possibility into a reported fact, or the position growing large enough that a bad outcome would matter to your whole portfolio regardless of who is right.

Bunge is a global agribusiness that sources, stores, processes, transports, and sells agricultural commodities and food ingredients. It is one of the world's largest oilseed processors and grain traders, operating across Agribusiness, Refined and Specialty Oils, and Milling segments.

Bunge completed its roughly $8 billion merger with Glencore-backed Viterra in July 2025, combining a top oilseed processor with a leading grain trader to form a group valued near $25 billion. The deal is meant to broaden Bunge's footprint and reduce reliance on any single commodity cycle.

That depends on your goals, time horizon, and risk tolerance, and Walnut is not an investment adviser. BG is a cyclical commodity business whose earnings swing with crush margins and trade flows, so it behaves very differently from a steady grower. Consider how that volatility fits your own portfolio and do your own research.